Loading…
Daniel Joseph Apel is Chief Financial Officer at Arrowhead Pharmaceuticals. OQRO lists 4 transactions filed with the SEC under this name, the latest on Apr 24, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
4
Companies involved
1
Arrowhead PharmaceuticalsARWR
4 disclosures · Jan 2026 – Apr 2026 · 3 sold
Apr 22, 2026Sold~$628Kdisclosed Apr 24
DetailsOfficial recordApr 22, 2026Sold~$225Kdisclosed Apr 24
DetailsOfficial recordApr 22, 2026Sold~$82Kdisclosed Apr 24
Jan 6, 202675Kdisclosed Jan 8
DetailsOfficial record